ライフサイエンスコーパス: TOF

1 TOF LCMS analyses identified two phenolic acids as the m

2 y active for dehydrogenation of formic acid (TOF = 1718 h(-1) and Ea = 31 kJ/mol) and one-pot reactio

3 ates exhibit a higher specific SCR activity (TOF).

4 Baseline non-TOF and TOF PET images were reconstructed.

5 In 40 and 50 of these cases (non-TOF and TOF, respectively), the detectability of the lesions did

6 The limit of detection for 1-HP by SFC-APLI-TOF(MS) was found to be 0.5 mug L(-1), which is lower th

7 o suggestive evidence of association between TOF and several additional single-nucleotide polymorphis

8 ose PET/computed tomography (CT) followed by TOF PET/MR imaging.

9 pproach has been used to improve a catalytic TOF by 10(4) vs the previously reported scaling relation

10 rganofluorine combustion-ion chromatography (TOF-CIC) revealed that fluorotelomer betaines were a sub

11 In our cohort, TOF was significantly associated with a genotyped single

12 III/II)) for the different cobalt complexes (TOF = turnover frequency).

13 on is much slower, under similar conditions (TOF=30 h(-1) ).

14 lyzed five commercial olive oils by HPLC-DAD-TOF/MS to evaluate their lignan content and detected, fo

15 arp of this fruit was studied using HPLC/ESI-TOF-MS.

16 the basis of the additional dimension of ESI-TOF-MS.

17 zation time-of-flight mass spectrometry (ESI-TOF-MS), thereby demonstrating the influence of differen

18 zation time-of flight mass spectrometry (ESI-TOF-MS).

19 erpotential of only 220 mV; the extrapolated TOF at zero overpotential is larger than 300 s(-1).

20 ter total correction of tetralogy of Fallot (TOF) are at risk for major complications.

21 % (n=326) of these have tetralogy of Fallot (TOF), comprising the largest subset of severe congenital

22 g its implementation to fast time-of-flight (TOF) analyzers which often lack the capability to perfor

23 ous PET/MR scanning for both time-of-flight (TOF) and non-TOF reconstructed PET images.

24 read function (PSF) or PSF + time-of-flight (TOF) for optimal tumor detection and also with standardi

25 ICR) mass spectrometer and a time-of-flight (TOF) instrument with lower mass resolving power.

26 Time-of-flight (TOF) ion profile was analyzed and charge emission depend

27 ation (MALDI) coupled with a time-of-flight (TOF) mass-spectrometry (MS) detector is acknowledged to

28 trated by the analysis of GC-time-of-flight (TOF) MS data from plasma samples of adolescents with hyp

29 nction (PSF) model-based and time-of-flight (TOF) PET.

30 ent dosimetry based on (90)Y time-of-flight (TOF) PET/CT.

31 raphy (PET) in an integrated time-of-flight (TOF) PET/magnetic resonance (MR) imaging system.

32 equency measurement) and via time-of-flight (TOF; time measurement).

33 acy and resolution, such as time-of-flights (TOFs) and Orbitraps.

34 The mean percentage error was -3.5% for TOF and -4.8% for non-TOF reconstructions, meaning that

35 The turnover frequencies (TOF) of these Lewis pair catalyzed processes were as hig

36 ntly achieving maximum turnover frequencies (TOF) regardless of the quality of the starting materials

37 rformances in terms of turnover frequencies (TOFs) are calculated based on the estimated number of ac

38 Turnover frequencies (TOFs) from chemical reduction (66 vs 6 h(-1)) and rate c

39 ble catalyst, reaching turnover frequencies (TOFs) of more than 25,000 h(-1) in 20% oleum with select

40 show trade-offs between turnover frequency (TOF) and the effective overpotential required to initiat

41 The maximal turnover frequency (TOF) is as high as 10(6) s(-1) and is reached at an over

42 3 % aqueous H2 O2 with a turnover frequency (TOF) of 16 000 h(-1) .

43 ne (H3 NBH3 , AB) with a turnover frequency (TOF) of 4896.8 h(-1) and an activation energy (Ea ) of 1

44 The turnover frequency (TOF) of the LDH-Au/CNTs COE catalyst was much higher tha

45 e somewhat decreases the turnover frequency (TOF) relative to ethylene homopolymerization, but still

46 ders of magnitude higher turnover frequency (TOF) than the best Rh-based catalysts and comparable to

47 igand conformation shows turnover frequency (TOF) values up to 60 000 h(-1) (0.1 mol % loading, 298 K

48 ogen in benzene, and the turnover frequency (TOF) was higher than other metals or the Rh homogeneous

49 ography-time-of-flight mass spectrometry (GC-TOF-MS) based metabolomics combined with partial least s

50 TD-GC-TOF-MS was used and a technique for the extraction of VO

51 trometry (GC-MS) and High Resolution GC x GC-TOF-MS (GC x GC HRT-4D).

52 hy-time-of-flight mass spectrometry (GC x GC-TOF-MS), and their identity were confirmed by comparison

53 ography/time-of-flight mass spectrometry (GC/TOF-MS), here used to examine the S. cerevisiae metabolo

54 A GCxGC-TOF/MS method was set up for the multiresidue analysis o

55 I) was evaluated as the ion source for GCxGC-TOF-MS measurements.

56 Nontargeted GCxGC-TOF/MS analysis of blubber from 8 common bottlenose dolp

57 with time-of-flight mass spectrometry (GCxGC-TOF MS).

58 or Italian sparkling wines, by HS-SPME-GCxGC-TOF-MS and multivariate analysis.

59 dentification power of PI coupled with GCxGC-TOF-MS is the first report covering volatiles to low-vol

60 aselines, and GC(2)MS is able to align GCxGC/TOF-MS data sets acquired under different experimental c

61 However, GCxGC/TOF-MS data processing is currently limited to vendor so

62 the application of recent advances in GCxGC/TOF-MS, especially for metabolomics studies.

63 zed by a nontargeted approach based on GCxGC/TOF-MS.

64 aphy time-of-flight mass spectrometry (GCxGC/TOF-MS) is superior for chromatographic separation and p

65 GC(2)MS treats GCxGC/TOF-MS data as pictures and clusters the pixels as blobs

66 GC(2)MS then aligns the blobs of two GCxGC/TOF-MS data sets according to their distance and similar

67 ormance of GC(2)MS was evaluated using GCxGC/TOF-MS data sets of Angelica sinensis compounds acquired

68 lithium derivative showed a remarkably high TOF of >/=17 s(-1).

69 omopolymerization, but still remarkably high TOFs of up to 4.5 x 10(5) h(-1) and overall productiviti

70 w approach for improving efficiencies-higher TOF at lower etaeff-by changing the concentrations and p

71 Larger particle size tended to show higher TOF and smaller reaction activation energy for Rh NPs en

72 with time-of-flight mass spectrometry (HPLC-TOF/MS) to show that the frugivorous Honduran white bat

73 time-of-flight mass spectrometry (LAESI-IMS-TOF-MS) was used for the analysis of synthetic polymers

74 aid peak information and background noise in TOF images made a precise assignment of molecular attrib

75 Positive and negative ion TOF-SIMS data were acquired directly from the C-4 residu

76 d and accurate method, by using the LC-MS-IT-TOF technology, to detect and quantify CBD, CBDV, Delta(

77 on-trap time-of-flight mass spectrometer (IT-TOF-MS) for the separation and identification of constit

78 a time-of-flight mass spectrometer (UPLC-IT-TOF-MS) that allowed the characterization of the toxin p

79 0.27 mg/g of lyophilized coral using UPLC-IT-TOF-MS.

80 /+) degradation series in the respective LDI-TOF MS studies.

81 zation time-of-flight mass spectrometry (LDI-TOF MS) studies of the crystalline samples show intense

82 A linear correlation is observed between log(TOF) vs E1/2(Co(III/II)) for the different cobalt comple

83 desorption/ionization time-of-flight (MALDI TOF) approaches have historically suffered from poor acc

84 An in vitro MALDI TOF MS-based activity assay that detects ricin mediated

85 MALDI-TOF mass spectrometry indicates that hydrogen peroxide b

86 MALDI-TOF MS analysis of the suspension after density-based se

87 MALDI-TOF MS has the potential to expedite mold identification

88 MALDI-TOF MS is a valuable tool for the identification of thes

89 MALDI-TOF MS plus AMS intervention significantly reduced the o

90 MALDI-TOF MS significantly improved TAT for organism ID.

91 MALDI-TOF MS was effective for the identification of mycobacte

92 MALDI-TOF score value identification identified correctly 46 S

93 MALDI-TOF was found as a useful and quick technique to obtain

94 MALDI-TOF-MS shows excellent potential for sensitive and rapid

95 fragment was detected at m/z 1088 by a MALDI-TOF mass spectrometry.

96 esses a novel bile solubility test and MALDI-TOF for the differentiation of Streptococcus pneumoniae

97 , we applied interference peptides and MALDI-TOF mass spectrometry to confirm APJ homo-dimer and expl

98 detection by single-base extension and MALDI-TOF mass spectrometry, in a novel method to assess multi

99 grees C using a spectrophotometer) and MALDI-TOF MS (both the standard result output and by visual sp

100 standardized culture, extraction, and MALDI-TOF MS analysis, isolates were identified using score cu

101 value (NPV) of MALDI-TOF MS alone and MALDI-TOF MS coupled with UA were 86.6% versus 93.4% (chi(2) =

102 cation (CONV), (ii) manual plating and MALDI-TOF MS identification (MALDI), (iii) MALDI-TOF MS identi

103 Chemical cross-linking and MALDI-TOF MS mapped these same regions to the PhuS:HemO protei

104 ity and that the combination of UA and MALDI-TOF MS provided an accurate and rapid detection and iden

105 nucleoplasts and Western blotting and MALDI-TOF of nuclear extracts show that Avp triggers Avpr1alph

106 ents in bulk by SDS-PAGE, RP-HPLC, and MALDI-TOF proves that the previous pepsin exposition promotes

107 rotein in A3HtrAOE with a mass, pI and MALDI-TOF spectrum consistent with outer membrane protein p66.

108 chniques such as RP-HPLC-UV, GFAAS and MALDI-TOF-MS allowed the identification of several proteins bo

109 applied microchip electrophoresis and MALDI-TOF-MS-based glycomic procedures to 20 control serum sam

110 saturation transfer difference-NMR and MALDI-TOF.

111 ant factors that must be considered as MALDI-TOF MS moves into applications beyond microbial identifi

112 scopy is a rapid technique, as fast as MALDI-TOF, and has been shown to accurately identify bacterial

113 Compared to previous attempts at MALDI-TOF mass spectrometric analysis of barley proteins, the

114 cavity was unambiguously validated by MALDI-TOF mass spectrometry and FTIR, Raman, and UV-vis absorp

115 (0.9%) isolates were misidentified by MALDI-TOF MS (including Aspergillus amoenus [n = 2] and Asperg

116 the substitution has been validated by MALDI-TOF MS analysis of the functionalized precursors and FT-

117 y testing of the samples identified by MALDI-TOF MS produced an overall categorical agreement of 99.2

118 ng bioconjugates were characterized by MALDI-TOF MS, differential scanning calorimetry (DSC), fluores

119 ISA, 21 hVISA, and 38 VSSA isolates by MALDI-TOF MS.

120 idin-3,5-O-diglycoside was verified by MALDI-TOF MS.

121 er species identification performed by MALDI-TOF MS.

122 SDS-PAGE and protein identification by MALDI-TOF MS.

123 detected peaks remained unresolved by MALDI-TOF, which led to a 3-5 times lower number of m/z featur

124 nd E nterobacter spp. were analyzed by MALDI-TOF-MS in negative ion mode to obtain glycolipid mass sp

125 Here we report combined MALDI-TOF MS experiments, NMR analyses and quantum mechanical/

126 desorption ionization time-of-flight (MALDI-TOF) mass spectrometric detection-are attractive analyti

127 desorption-ionization time-of-flight (MALDI-TOF) mass spectrometry (MS).

128 desorption/ionization time of flight (MALDI-TOF) mass spectrometry and nuclear magnetic resonance (N

129 desorption ionization-time of flight (MALDI-TOF) mass spectrometry for the detection of organisms ca

130 desorption ionization-time of flight (MALDI-TOF) mass spectrometry might allow the accurate identifi

131 desorption/ionization-time of flight (MALDI-TOF) mass spectrometry revealed identical SIFamide seque

132 desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.

133 desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.

134 desorption/ionization time of flight (MALDI-TOF) mass spectrometry.

135 desorption ionization-time of flight (MALDI-TOF) methodology, suggesting that MALDI-TOF can offer ra

136 desorption ionization-time of flight (MALDI-TOF) MS organism identification and automated-system-bas

137 Desorption/Ionization Time-of-Flight (MALDI-TOF) technique for bacterial identification after cultur

138 hip, including the matrix delivery for MALDI-TOF analysis.

139 ed smaller peptides, as evidenced from MALDI-TOF spectrometry.

140 I-TOF MS identification (MALDI), (iii) MALDI-TOF MS identification and early phase implementation of

141 elevant Nocardia spp. and to implement MALDI-TOF MS libraries developed by single laboratories across

142 e the additional costs of implementing MALDI-TOF and of dedicating pharmacy stewardship personnel tim

143 Implementing MALDI-TOF plus stewardship review and intervention decreased m

144 ed characteristic isotopic patterns in MALDI-TOF MS, and both a fragmentation product y1 ion correspo

145 onisation properties and resolution in MALDI-TOF-MS, these phosphopeptides were identified as suitabl

146 assisted laser desorption/ionization (MALDI-TOF) mass spectrometry (MS).

147 -assisted laser desorption/ionization (MALDI-TOF-MS) for determination of Cu, Fe, Mn and Zn and ident

148 s centered around m/z = 733 amu in its MALDI-TOF mass spectrum, consistent with the formation of the

149 implementation of TLA (TLA1), and (iv) MALDI-TOF MS identification and late phase implementation of T

150 ty of the Bruker Biotyper and Vitek MS MALDI-TOF MS systems and their in vitro diagnostic (IVD), rese

151 B and 1.2 x 10(5) J/m(2) UVA), neither MALDI-TOF-MS nor RT-qPCR detected significant decreases in the

152 Nevertheless, MALDI-TOF allowed reproducing and verifying individual markers

153 red, demonstrate the value of this new MALDI-TOF MS method as an analytical tool for the identificati

154 dia isolates, and NIH and OSU Nocardia MALDI-TOF MS libraries were distributed to three centers.

155 supplementation of the Bruker Nocardia MALDI-TOF MS library with both the OSU and NIH libraries incre

156 ystem and included additional costs of MALDI-TOF equipment, supplies and personnel, and dedicated pha

157 and negative predictive value (NPV) of MALDI-TOF MS alone and MALDI-TOF MS coupled with UA were 86.6%

158 is study was to evaluate the impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time

159 Use of MALDI-TOF MS and TLA individually and together results in sign

160 aluated the capacity of combination of MALDI-TOF MS and urine analysis (UA) for direct detection and

161 ee sites, while specificity and NPV of MALDI-TOF MS for males were significantly higher than those fo

162 s review discusses the various uses of MALDI-TOF MS for the identification and susceptibility testing

163 his work, we report the specificity of MALDI-TOF MS for the identification of 162 Mycobacterium speci

164 in the databases and in the ability of MALDI-TOF MS to rapidly identify slowly growing mycobacteria a

165 specificity study, the performance of MALDI-TOF MS was directly compared with that of 16S rRNA gene

166 cks before and after implementation of MALDI-TOF plus stewardship intervention.

167 5 h and automated data acquisition on MALDI-TOF-MS took on average less than 1 min per sample.

168 )H NMR and DI-LC-MS/MS) and proteomic (MALDI-TOF/TOF-MS) platforms.

169 Following UV254 exposure, quantitative MALDI-TOF-MS detected significantly more RNA modifications tha

170 species were used to create reference MALDI-TOF spectra, which were then used for the identification

171 tion-time-of-flight mass spectrometry (MALDI-TOF MS) after enzymatic digestion of the polysaccharide

172 tion-time of flight mass spectrometry (MALDI-TOF MS) and BD Kiestra total laboratory automation (TLA)

173 tion-time of flight mass spectrometry (MALDI-TOF MS) and evaluated the capacity of combination of MAL

174 tion-time of flight mass spectrometry (MALDI-TOF MS) decreases the time to organism identification an

175 on - time-of-flight mass spectrometry (MALDI-TOF MS) fingerprinting of proteins was developed.

176 tion-time of flight mass spectrometry (MALDI-TOF MS) for rapid organism identification and dedicating

177 tion-time of flight mass spectrometry (MALDI-TOF MS) for the identification of bacteria and yeasts is

178 tion time of flight mass spectrometry (MALDI-TOF MS) for the identification of Exophiala species.

179 tion-time of flight mass spectrometry (MALDI-TOF MS) for the identification of NTM isolated on RGM me

180 tion-time of flight mass spectrometry (MALDI-TOF MS) has become the standard for routine bacterial sp

181 tion-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and accurate method for i

182 tion-time of flight mass spectrometry (MALDI-TOF MS) has reduced the time to identification of cultur

183 tion-time of flight mass spectrometry (MALDI-TOF MS) has revolutionized clinical microbiology for iso

184 tion-time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial steward

185 tion time-of-flight mass spectrometry (MALDI-TOF MS) platforms in the medical microbiological practic

186 tion-time of flight mass spectrometry (MALDI-TOF MS) sample preparation methods, including the direct

187 sorption/ionization mass spectrometry (MALDI-TOF MS) that allows quantification of pure or mixed dete

188 tion-time of flight mass spectrometry (MALDI-TOF MS) to detect pKpQIL_p019 (p019)-an approximately 11

189 tion-time of flight mass spectrometry (MALDI-TOF MS), suspicious isolates are now routinely identifie

190 tion-time of flight mass spectrometry (MALDI-TOF MS)-based identifications of the flown and stationar

191 tion-time of flight mass spectrometry (MALDI-TOF MS).

192 tion-time of flight mass spectrometry (MALDI-TOF MS).

193 me-of-flight tandem mass spectrometry (MALDI-TOF MS/MS), we now reveal that actually up to five fucos

194 tion time-of-flight mass spectrometry (MALDI-TOF) and the determination of their amino acid sequences

195 tion time-of-flight mass spectrometry (MALDI-TOF-MS) analysis of high abundance proteins is gaining p

196 tion-time-of-flight-mass spectrometry (MALDI-TOF-MS) is presented.

197 tion time-of-flight mass spectrometry (MALDI-TOF-MS) method and corresponding mathematic matrix to de

198 - time of flight - mass spectrometry (MALDI-TOF-MS).

199 d and identified by mass spectrometry (MALDI-TOF/MS).

200 tion time-of-flight mass spectrometry (MALDI-TOF/TOF MS) were used to assess the different protein ex

201 dentified by tandem mass spectrometry (MALDI-TOF/TOF).

202 ight/time-of-flight mass spectrometry (MALDI-TOF/TOF-MS) for sequential identification of the peptide

203 ight/time-of-flight mass spectrometry (MALDI-TOF/TOF-MS).

204 In summary, MALDI-TOF MS allows the rapid and accurate identification of a

205 MS intervention is more impactful than MALDI-TOF MS alone.

206 ynamic range and higher precision than MALDI-TOF MS, while still generating results in a similar time

207 ALDI-TOF) methodology, suggesting that MALDI-TOF can offer rapid, reliable identification in line wit

208 Here, we demonstrate that MALDI-TOF mass spectrometry accurately identified all of the t

209 Our work shows that MALDI-TOF mass spectrometry is suitable for quantitative bioma

210 der of reactivity as observed with the MALDI-TOF mass spectrometry assay.

211 r aerobic actinomycetes using both the MALDI-TOF MS manufacturer's supplied database(s) and a custom

212 ining the bile solubility test and the MALDI-TOF spectra results provide a correct identification of

213 The MALDI-TOF spectrum showed the presence of pseudo-proteins >7 k

214 ation with minimal side reactions: the MALDI-TOF-MS profiles obtained were in good agreement with hyd

215 AMS intervention included: real-time MALDI-TOF MS pharmacist notification and prospective AMS provi

216 ion highlights the challenges of using MALDI-TOF mass spectrometry for purposes other than organism i

217 Now, using MALDI-TOF mass spectrometry, we report that transmembrane muci

218 ng to pre-TLA and post-TLA, both using MALDI-TOF MS for organism identification.

219 cylglycerol) in complex mixtures using MALDI-TOF-MS with fractional factorial design (FFD) and Pareto

220 l microbiology laboratories to utilize MALDI-TOF MS for the rapid identification of clinically releva

221 he impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time, pharmacist-driven, antim

222 positive blood cultures identified via MALDI-TOF MS combined with prospective AMS intervention compar

223 gainst all Exophiala isolates in vitro MALDI-TOF MS successfully distinguished all 18 species and ide

224 ptibility testing might be useful when MALDI-TOF MS results in an organism identification, and it mig

225 described in this study was SOD, while MALDI-TOF analysis confirmed only SOD from erythrocytes.

226 al outcomes, rapid identification with MALDI-TOF MS combined with real-time AMS intervention is more

227 tion compared to a control cohort with MALDI-TOF MS identification without AMS intervention.

228 In this work MALDI-TOF mass spectroscopy was investigated to characterise t

229 , but the closed-path nature of executing MR-TOF in an ELIT limits both the m/z range and the peak ca

230 tireflection time-of-flight mass spectra (MR-TOF MS).

231 increases much faster with time with the MR-TOF approach, for example, but the closed-path nature of

232 for wide m/z range applications, whereas MR-TOF MS can provide advantages in a "zoom-in" mode in whi

233 soflavonoids, an efficient analytical LC-MS (TOF) technique was used.

234 spectrometry-time-of-flight analysis (LC-MS-TOF), we developed a workflow for the identification of

235 m mass spectrometry-time of-flight (LC-MS/MS-TOF)) in conjunction with inductively coupled plasma mas

236 ere new methodology that allows for multiple TOF/TOF fragmentation events to be performed in a single

237 lesion diameters of up to 17 mm on no-PSF no-TOF PET, (124)I activities as high as 170 MBq may be war

238 for large lesions (>10 mm) and for no-PSF no-TOF PET, since DEPs are greater than 1%.

239 ses, the detectability changed; and in 2 non-TOF cases, the lesions were no longer visible after the

240 We have presented a non-TOF emission-based approach for estimating the attenuati

241 anning for both time-of-flight (TOF) and non-TOF reconstructed PET images.

242 Baseline non-TOF and TOF PET images were reconstructed.

243 In 40 and 50 of these cases (non-TOF and TOF, respectively), the detectability of the les

244 hesis, on integrated non-time-of-flight (non-TOF) PET/MRI scanners.

245 ge error was -3.5% for TOF and -4.8% for non-TOF reconstructions, meaning that the inclusion of TOF i

246 Energy span and degree of TOF control analysis strongly support experimental obser

247 The dependence of TOF on etaeff is shown to be quite different upon changi

248 constructions, meaning that the inclusion of TOF information reduced the percentage error in SUVmax b

249 The inclusion of TOF information significantly reduced artifacts due to s

250 With use of TOF PET data, PET images were reconstructed with four di

251 ilar lesion detectability between (124)I PSF TOF PET/CT and (131)I SPECT/CT for small spheres (</=10

252 was applied to the PSF +/- TOF data (PSF +/- TOF.EQ) to harmonize SUVs with the OSEM values.

253 software solution was applied to the PSF +/- TOF data (PSF +/- TOF.EQ) to harmonize SUVs with the OSE

254 action-time-of-flight mass spectrometer (PTR-TOF) using a new gas inlet and an innovative reaction ch

255 action time-of-flight mass spectrometry (PTR-TOF-MS).

256 ncrease in pressure compared to standard PTR-TOF-MS.

257 HPLC-ESI-Q-TOF allowed the detection of 25 different raw formulas m

258 pole-time-of-flight mass spectrometry (ESI-Q-TOF MS).

259 ionization quadrupole time-of-flight (ESI-Q-TOF) mass spectrometry was used to investigate protein g

260 ully applied in quadrupole time-of-flight (Q-TOF) instruments.

261 generated on a quadrupole-time-of-flight (Q-TOF).

262 upole time-of-flight mass spectrometry (LC-Q-TOF-MS) was utilized to acquire metabolic profiles of mu

263 upole time-of-flight mass spectrometry (LC-Q-TOF-MS)-based global metabolomics analysis.

264 However, the mass resolution of Q-TOF instruments can limit the information that can be ob

265 onsistent with data previously acquired on Q-TOF platforms, matching predictions from known protein i

266 adrupole time-of-flight mass spectrometry (Q-TOF MS).

267 Untargeted metabolite profiling by UPLC-Q-TOF mass spectrometry, followed by uni- and multivariate

268 ttle was investigated by FTICR-MS and UPLC-Q-TOF-MS.

269 ariety of electrospray-MS strategies using Q-TOF technology were used to define this entity, includin

270 time of flight-mass spectrometry (UPLC-PDA-Q/TOF-MS) method.

271 raphy coupled to tandem mass spectrometry (Q/TOF) for the identification and relative quantification

272 uple and time-of-flight mass spectrometry (Q/TOF, TQ-S).

273 PD studies that the sensitivity of the REMPI-TOF-MS is comparable to commercial EI-Q-MS solutions and

274 In patients with repaired TOF, biventricular dysfunction on CMR imaging was associ

275 performed, resulting in the highest reported TOF of 3200 h(-1) together with 99% polycarbonate select

276 ex also displays one of the highest reported TOF values for H2 oxidation, 72 s(-1), of any homogeneou

277 osemicarbazide) display the highest reported TOFs of any homogeneous ligand-centered H2 evolution cat

278 ross nine different MS instruments (1 single TOF, 1 Q/orbital ion trap, and 7 QTOF instruments).

279 ionization time-of-flight mass spectrometry (TOF-MS) allows the detection of thousands of compounds.

280 e-of-flight-secondary ion mass spectrometry (TOF-SIMS) and laser ablation-inductively coupled plasma

281 e-of-flight secondary ion mass spectrometry (TOF-SIMS).

282 The TOF ion profile exhibits two peaks corresponding to a fa

283 The TOF of 27-34 s-1 and 42-48 s-1 for Mo-pic and Mo-pym and

284 The TOF-SIMS data was combined with a second analytical meth

285 ation on the three-membered ring boosted the TOF of ring opening.

286 old lowers etaeff by 59 mV and decreases the TOF by a factor of 10.

287 owers etaeff by 59 mV but only decreases the TOF by a factor of 2.

288 The TOFs are more than 3 orders of magnitude higher compared

289 The data show that the TOFs of the Co complexes exhibit a shallower dependence

290 onclusion, common variants may contribute to TOF in 22q11.2DS and may function in cardiac outflow tra

291 hy tandem mass spectrometry on a 6600 Triple-TOF mass spectrometer.

292 enated heterocyclic compounds (OHC) by UHPLC/TOF-HRMS, multivariate data analysis (PCA, PLS-DA) and m

293 tify common genetic variants associated with TOF in individuals with 22q11.2DS, we performed a genome

294 screening of a complex matrix chemistry with TOF-SIMS (MS(1)) imaging and targeted identification of

295 S(+) radical scavenging assay and LC-MS with TOF-MS for compositional analysis of the most potent ant

296 enter study included 575 adult patients with TOF (4.083 patient-years at risk) from a prospective nat

297 Of the 575 patients with TOF, 57% were male, and the mean (SD) age was 31 (11) ye

298 site that possibly may go unnoticed without TOF information.

299 uted from the (99m)Tc-MAA SPECT/CT and (90)Y TOF PET/CT data.

300 ed doses calculated from posttreatment (90)Y TOF PET/CT for tumor and nontumor tissues.